Cite
HARVARD Citation
Bauer, A. et al. (2021). Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial. Lancet. 9 (8), pp. 863-872. [Online].